Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RNU6-1079P represents a specific human U6 small nuclear RNA-derived pseudogene. The functional U6 snRNA is a non-coding RNA crucial for splicing in the spliceosome, where it catalyzes intron excision from pre-mRNAs[3][1]. Pseudogenes like RNU6-1079P arise in the genome by retrotransposition mechanisms, often via LINE elements, and do not produce functional RNA or protein. The majority of such pseudogenes are considered non-functional relics and are not involved in cellular mechanisms, regulation, or disease[2][4][5]. Their presence is used primarily in genomics and evolutionary studies to track retrotransposition events and lineage-specific genome changes[2].
None; no therapeutic mechanism applies
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RNA, U6 small nuclear 1079, pseudogene (RNU6-1079P).